GWM Advisors LLC
- SEC CIK
- 0001633516
- Latest filing
- Aug 12, 2026
CPRX holding history
Catalyst Pharmaceuticals, Inc. in every 13F filed by GWM Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −56−100.0% | Sold out | Holders |
| Q1 2025 | 56 | $1.36K | <0.1% | +1+1.8% | Added | Holders |
| Q4 2024 | 55 | $1.15K | <0.1% | +55 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −70−100.0% | Sold out | Holders |
| Q2 2024 | 70 | $1.08K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 70 | $1.12K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 70 | $1.18K | <0.1% | −3,196−97.9% | Reduced | Holders |
| Q3 2023 | 3,266 | $38.2K | <0.1% | +226+7.4% | Added | Holders |
| Q2 2023 | 3,040 | $40.9K | <0.1% | −18,626−86.0% | Reduced | Holders |
| Q1 2023 | 21,666 | $359.2K | <0.1% | −8,392−27.9% | Reduced | Holders |
| Q4 2022 | 30,058 | $331.0K | <0.1% | +1,223+4.2% | Added | Holders |
| Q3 2022 | 28,835 | $370.0K | <0.1% | +28,835 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −19,189−100.0% | Sold out | Holders |
| Q1 2022 | 19,189 | $159.0K | <0.1% | +19,189 | New | Holders |